Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (22)

2019

  1. Mechanisms Underlying the Antihypertensive and Vasodilatory Effects of Qingda Granules

    Journal of cardiovascular pharmacology, Vol. 74, Núm. 6, pp. 511-512

2018

  1. Chronic exercise improves mitochondrial function and insulin sensitivity in brown adipose tissue

    Frontiers in Physiology, Vol. 9, Núm. AUG

2016

  1. Aldosterone induces renal fibrosis and inflammatory M1-macrophage subtype via mineralocorticoid receptor in rats

    PLoS ONE, Vol. 11, Núm. 1

2013

  1. Factors involved in rosuvastatin induction of insulin sensitization in rats fed a high fat diet

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 23, Núm. 11, pp. 1107-1114

  2. Relevance of vascular peroxisome proliferator-activated receptor γ coactivator-1α to molecular alterations in atherosclerosis

    Experimental Physiology, Vol. 98, Núm. 5, pp. 999-1008

  3. Splanchnic-aortic inflammatory axis in experimental portal hypertension

    World Journal of Gastroenterology, Vol. 19, Núm. 44, pp. 7992-7999

2012

  1. A wound-like inflammatory aortic response in chronic portal hypertensive rats

    Molecular Immunology, Vol. 51, Núm. 2, pp. 177-187

  2. Effects of lipopolysaccharide on the neuronal control of mesenteric vascular tone in rats: Mechanisms involved

    Shock, Vol. 38, Núm. 3, pp. 328-334

  3. Portal hypertensive cardiovascular pathology: The rescue of ancestral survival mechanisms?

    Clinics and Research in Hepatology and Gastroenterology

2011

  1. Exposure to low mercury concentration in vivo impairs myocardial contractile function

    Toxicology and Applied Pharmacology, Vol. 255, Núm. 2, pp. 193-199

  2. Rosuvastatin restored adrenergic and nitrergic function in mesenteric arteries from obese rats

    British Journal of Pharmacology, Vol. 162, Núm. 1, pp. 271-285

2009

  1. Inflammation: A link between hypertension and atherosclerosis

    Current Hypertension Reviews, Vol. 5, Núm. 1, pp. 40-48

2007

  1. Interactions between aldosterone and connective tissue growth factor in vascular and renal damage in spontaneously hypertensive rats

    Journal of Hypertension, Vol. 25, Núm. 3, pp. 629-638

2005

  1. Eplerenone reduces oxidative stress and enhances eNOS in SHR: Vascular functional and structural consequences

    Antioxidants and Redox Signaling, Vol. 7, Núm. 9-10, pp. 1294-1301

  2. Participation of aldosterone in the vascular inflammatory response of spontaneously hypertensive rats: Role of the NFκB/IκB system

    Journal of Hypertension, Vol. 23, Núm. 6, pp. 1167-1172

  3. Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats

    Hypertension, Vol. 46, Núm. 1, pp. 107-112

2004

  1. Aldosterone modulates neural vasomotor response in hypertension: Role of calcitonin gene-related peptide

    Regulatory Peptides, Vol. 120, Núm. 1-3, pp. 253-260

  2. Chronic L-arginine treatment reduces vascular smooth muscle cell hypertrophy through cell cycle modifications in spontaneously hypertensive rats

    Journal of Hypertension, Vol. 22, Núm. 4, pp. 751-758

2003

  1. Effect of AT 1 receptor blockade on hepatic redox status in SHR: Possible relevance for endothelial function?

    American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 285, Núm. 3 54-3

1999

  1. Participación de los factores constrictores derivados del endotelio en la hipertensión arterial

    Revista Espanola de Cardiologia, Vol. 52, Núm. SUPPL. 3, pp. 4-11